1. Home
2. Raw materials
3. Other antibacterials

Other antibacterials

The category of pther antibacterials in the pharmaceutical API (Active Pharmaceutical Ingredient) industry encompasses a diverse range of antibacterial substances that are not classified under specific subcategories. These APIs exhibit potent antibacterial activity against various bacteria and play a crucial role in combating bacterial infections.

The Other antibacterials category includes several subclasses of pharmaceutical APIs, such as nitroimidazoles, fusidanes, polymyxins, and glycopeptides. Each subclass comprises specific chemical compounds that target different types of bacteria through distinct mechanisms of action.

Nitroimidazoles are effective against anaerobic bacteria and protozoa by interfering with their DNA replication. They are commonly used in the treatment of infections in the gastrointestinal tract, pelvic area, and respiratory system. Fusidanes, on the other hand, inhibit bacterial protein synthesis and are particularly active against Gram-positive bacteria. They find application in treating skin and soft tissue infections caused by Staphylococcus aureus.

Polymyxins are cyclic peptides that disrupt the integrity of bacterial cell membranes, rendering them inactive. These APIs are potent against Gram-negative bacteria and are often reserved for multidrug-resistant strains.

Glycopeptides, such as vancomycin, are essential for combating Gram-positive bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA). They inhibit bacterial cell wall synthesis, leading to bacterial death.

The Other antibacterials category plays a critical role in providing effective treatment options for bacterial infections, particularly when other classes of antibacterials have shown limited efficacy. Pharmaceutical companies continually explore and develop new compounds within this category to address emerging antibiotic resistance and enhance patient care.